Jarushka Naidoo: Clinical presentation and outcomes of ICI-encephalitis
Jarushka Naidoo shared on X:
“Pleased to share our paper on clinical presentation and outcomes of ICI-encephalitis:
– 132 patients in literature and 14 patients at JHU
– all treated with steroids, 26%+IVIG, 12%+ritux
– full recovery in >80%, no deaths.”
Immune-related encephalitis after immune checkpoint inhibitor therapy
Autors: Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, Laura C Cappelli, William H Sharfman, Ephraim Fuchs, Hyunseok Kang, Patrick M Forde, Douglas E Gladstone, Richard Ambinder, Ronan J Kelly, Evan J Lipson, Ivana Gojo, Edward J Lee, Tory P Johnson, Shiv Saidha, Rafael Llinas, Lyle W Ostrow, Jarushka Naidoo, John C Probasco
Source: Jarushka Naido/X
Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials.
She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023